TP53 and cancer: It is thus unsurprising that p53 is one of the most frequently mutated oncoproteins in human cancers, with >50% cancers displaying mutations in one or both TP53 alleles; such mutations can cause loss or gain of function in p53 activity that contributes to tumorigenesis [8].